Ready-made stem cell therapies for pets could be coming

Ready-made stem cell therapies for pets could be coming

Earlier this week, San Diego startup Gallant announced $18 million in funding to bring the first FDA-approved ready-to-use stem cell therapy to veterinary medicine. If it passes regulatory muster, it could create a whole new way to treat our fur babies. It’s still an experimental field, even though people have been researching stem cells for…

Read More
Why AI will eat McKinsey’s lunch — but not today

Why AI will eat McKinsey’s lunch — but not today

Navin Chaddha, managing director of the 55-year-old Silicon Valley venture firm Mayfield, is betting big on AI’s ability to transform people-heavy industries like consulting, law, and accounting. The veteran investor, whose wins include Lyft, Poshmark, and HashiCorp, recently discussed at TechCrunch’s StrictlyVC evening in Menlo Park why he believes “AI teammates” can create software-like margins…

Read More